Featured speaker: Mr Larry Ajuwon, #Genzyme

In Clinical Trials by valerie limLeave a Comment

Our featured speaker for today is Mr Larry Ajuwon, Senior Outsourcing, Genzyme, The Netherlands. He will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.

A brief introduction to start with: In his current role, Mr Ajuwon negotiates and manages contracts and collaborations for clinical development teams covering Europe, MENA and India. He joined the pharmaceutical industry in 2000, starting in Clinical Data Management at Smithkline Beecham/GSK, Wyeth (UK) and was later drafted to Clinical Contracting/Outsourcing at Pfizer (Spain). He is an analytical Chemist by training and has worked in the laboratories of CocaCola, Technicolor and Johnson Mathey from 1998-2000 to assay soft drinks, chemicals and precious metals. Mr Ajuwon graduated from the University of London and took a post graduate study in Cooperative Strategy. He is currently a member of the International Association of Contract and Commercial Management (IACCM), PCMG and is a Certified Project Management Professional. Mr Ajuwon is also a strong supporter of drug development projects for neglected diseases with his involvement in euSEND, European Solutions Enterprise for Neglected Diseases, a Netherlands based Public Private Partnership.

Mr Ajuwon will be participating in the following panel discussion on the 20th of March:

Panel: Determining your business strategy in Asia: Not one size fits all – Customising solutions for different needs
1. Weighing between the pros and cons of in-house clinical development in Asia vs outsourcing for global submissions
2. Assessing financial risks and quality management issues for clinical trial integrity
3. Evaluating the advantages of using a single CRO vs multi-CRO partners to maximise trial effectiveness

If you are keen to find out more, join us at BioPharma Asia Convention 2012 to gain valuable insights from more than 200 experts. Contact us now for more details!

Leave a Comment

Current ye@r *